Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
104.00
+3.80 (3.79%)
At close: Apr 28, 2026
-10.19%
Market Cap 23.15B
Revenue (ttm) 14.78B
Net Income (ttm) 1.24B
Shares Out 231.00M
EPS (ttm) 5.36
PE Ratio 18.70
Forward PE n/a
Dividend 2.10 (2.10%)
Ex-Dividend Date Nov 17, 2025
Volume 897,484
Average Volume 258,504
Open 102.00
Previous Close 100.20
Day's Range 102.00 - 106.00
52-Week Range 92.40 - 147.50
Beta -0.44
RSI 45.42
Earnings Date Apr 27, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointesti... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,771
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In fiscal year 2025, Beacon Pharmaceuticals's revenue was 12.54 billion, an increase of 17.20% compared to the previous year's 10.70 billion. Earnings were 946.51 million, an increase of 81.67%.

Financial Statements

News

There is no news available yet.